News Headline Summary

Eli Lilly's (LLY) Tabalumab receives orphan drug designation for multiple Myeloma treatment

Reaction details:

- Co. shares unreactive to the latest announcement, up 0.36% at USD 47.36 last.

Print 19:03, 21 Nov 2012 - US Equities - Source: Newswires